How to Tackle Discordance in Adjuvant Chemotherapy Recommendations by Using Oncotype DX Results, in Early-Stage Breast Cancer.
Katalin BoérAmbrus KaposiJudit KocsisZsolt HorváthBalázs MadarasÁkos SávoltGyorgy Benjamin KlémentGabor RubovszkyPublished in: Cancers (2024)
The Oncotype DX test substantially improves decision accuracy in recommending adjuvant chemotherapy. It may be further improved with a consensus decision. In the case of pre-RS consensus against chemotherapy, the test can be spared.